Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease

New England Journal of Medicine

Volumn 348, Issue 26, 2003, Pages 2679-2681

  Irwin, Richard S ^a   Madison, J Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDICATION; DRUG USE; DYSPNEA; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; PRIORITY JOURNAL; TREATMENT INDICATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; GLUCOCORTICOIDS; HUMANS; PREDNISONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE;

EID: 0037972512     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe030034     Document Type: Editorial

References (19)

1. Mannino DM, Homa DM, Aldnbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWP, CDC Surveill Summ 2002;51:(SS-6):1-16.
2. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
4. Snider GL. Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:678-83.
5. Madison JM, Irwin RS. Chronic obstructive pulmonary disease. Lancet 1998;352:467-73.
6. Pauwels RA, Buist AS, Calverley PM, Jenkins CP, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
7. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 2000;117:Suppl 2:38OS-385S.
8. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273:957-60.
9. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest 2001;119:1190-209.
10. Singh JM, Palda VA, Stanbrook MB, Chapman KR. Corticosteroid therapy for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med 2002;162:2527-36.
11. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003;348:2618-25.
12. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD: clinical practice guideline. Chest 2001;119:1185-9.
13. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991;114:216-23.
14. Rice KL, Rubins JB, Lebahn F, et al. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. Am J Respir Crit Care Med 2000;162:174-8.
15. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000;356:1480-5.
16. Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002;113:59-65.
17. Van der Valk P, Monninkoff E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 2002;166:1358-63.
18. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-56.
19. McEvoy CE, Niewoehner DE. Adverse effects of corticosteroid therapy for COPD: a critical review. Chest 1997;111:732-43.